Novartis Pharmaceuticals Corporation offers several programs that can help patients with advanced systemic mastocytosis (SM)* who are prescribed RYDAPT® (midostaurin) capsules access treatment, as well as help eligible patients with out-of-pocket co-pay costs.
*Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL) are 3 types of SM and are collectively referred to as advanced SM.
RYDAPT NOW Free Supply Program
If you are prescribed RYDAPT for advanced SM, you may be eligible to receive a free 28-day supply of RYDAPT shipped directly to your home or another convenient location, allowing you to begin therapy quickly.
No purchase of RYDAPT is required. Novartis cannot guarantee that every patient who enrolls in RYDAPT NOW will be successful in obtaining insurance coverage for treatment.
RYDAPT NOW—a partner during your journey
Novartis Patient Assistance Now Oncology and the whole team at RYDAPT NOW are here to help you navigate the path along your treatment journey.
During advanced SM treatment with RYDAPT, Care Coordinators are there to support you by:
Offering support with insurance verification to help you understand how to get your medicine and what your financial responsibilities are, and providing information about prior authorization requirements
Helping you find a pharmacy based on your insurance plan, and get your medicine according to your plan's guidelines
Providing information about financial assistance that may be available
Novartis cannot guarantee that every patient who enrolls in RYDAPT NOW will be successful in obtaining insurance coverage for treatment or will receive financial assistance.
Call 1-800-282-7630 for information on how to enroll in RYDAPT NOW and to learn more about the ways we can help.